Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.
4.
5.

Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.

Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P.

Medicine (Baltimore). 1996 Jan;75(1):17-28.

6.

Gastrointestinal tract involvement in polyarteritis nodosa and Churg-Strauss syndrome.

Guillevin L, Lhote F, Gallais V, Jarrousse B, Royer I, Gayraud M, Benichou J.

Ann Med Interne (Paris). 1995;146(4):260-7.

PMID:
7653948
7.
9.

Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients.

Bourgarit A, Le Toumelin P, Pagnoux C, Cohen P, Mahr A, Le Guern V, Mouthon L, Guillevin L; French Vasculitis Study Group.

Medicine (Baltimore). 2005 Sep;84(5):323-30.

10.

Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.

Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, Jarrousse B; French Vasculitis Study Group.

Arthritis Rheum. 2001 Mar;44(3):666-75.

11.

Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides.

Gayraud M, Guillevin L, Cohen P, Lhote F, Cacoub P, Deblois P, Godeau B, Ruel M, Vidal E, Piontud M, Ducroix JP, Lassoued S, Christoforov B, Babinet P.

Br J Rheumatol. 1997 Dec;36(12):1290-7.

PMID:
9448590
12.

Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.

Ribi C, Cohen P, Pagnoux C, Mahr A, Arène JP, Lauque D, Puéchal X, Letellier P, Delaval P, Cordier JF, Guillevin L; French Vasculitis Study Group.

Arthritis Rheum. 2008 Feb;58(2):586-94. doi: 10.1002/art.23198.

13.
14.

A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.

Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, Lesavre P, Jacquot C, Bindi P, Bielefeld P, Desson JF, Détrée F, Dubois A, Hachulla E, Hoen B, Jacomy D, Seigneuric C, Lauque D, Stern M, Longy-Boursier M.

Arthritis Rheum. 1997 Dec;40(12):2187-98.

PMID:
9416856
16.

Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients.

Ribi C, Cohen P, Pagnoux C, Mahr A, Arène JP, Puéchal X, Carli P, Kyndt X, Le Hello C, Letellier P, Cordier JF, Guillevin L; French Vasculitis Study Group.

Arthritis Rheum. 2010 Apr;62(4):1186-97. doi: 10.1002/art.27340.

17.

Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients.

Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P.

Medicine (Baltimore). 1999 Jan;78(1):26-37.

18.

Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients.

Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E, Cohen P; French Vasculitis Study Group.

Medicine (Baltimore). 2005 Sep;84(5):313-22.

19.

Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome.

Danieli MG, Cappelli M, Malcangi G, Logullo F, Salvi A, Danieli G.

Ann Rheum Dis. 2004 Dec;63(12):1649-54.

20.

Supplemental Content

Support Center